Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening

NCT06879834 is registered in ClinicalTrials.gov with The Filatov Institute of Eye Diseases and Tissue Therapy as lead sponsor.

NCT NCT06879834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06879834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening
Lead sponsor
The Filatov Institute of Eye Diseases and Tissue Therapy
Phase
Observational
Overall status
Recruiting
Start date
November 2, 2024
Completion date
December 31, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy